EPWK Holdings Ltd. (EPWK)

CTI BioPharma Revenue

EPWK Holdings had revenue of $8.48M in the half year ending December 31, 2024, a decrease of -15.57%. This brings the company's revenue in the last twelve months to $20.16M, up 10.25% year-over-year. In the fiscal year ending June 30, 2024, EPWK Holdings had annual revenue of $20.22M with 2.10% growth.

• Revenue (ttm): $20.16M
• Revenue Growth: +10.25%
• P/S Ratio: 0.44
• Revenue / Employee: $109,587
• Employees: 184
• Market Cap: 8.96M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2024	20.22M	414.85K	2.10%
Jun 30, 2023	19.80M	6.99M	54.56%
Jun 30, 2022	12.81M	1.44M	12.71%
Jun 30, 2021	11.37M	-1.54M	-11.93%
Jun 30, 2020	12.91M	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.